Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Vericel Corp (VCEL)  
$46.05 0.60 (1.32%) as of 4:30 Fri 4/26


Download
   
Exchange: Nasdaq Small Cap
Security Type: Common
Shares Out: 52,373,000
Market Cap: 2.41(B)
Last Volume: 0 Avg Vol: 0
52 Week Range: $30.76 - $52.9
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Laboratories & Research

Member Indexes:
    NASDAQ COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  474
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Vericel is a biopharmaceutical company providing cell therapies for the sports medicine and severe burn care markets. Co.'s products include: MACI®, which is an autologous cellularized scaffold product indicated for the repair of symptomatic, full-thickness cartilage defects of the knee with or without bone involvement in adults; and Epicel®, which is a permanent skin replacement for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns comprising greater than or equal to 30% of total body surface area. Co. also holds a license for North American rights to NexoBrid®, a registration-stage biological orphan product for debridement of severe thermal burns.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 137,038 259,234 263,234 304,733
Total Sell Value $6,290,967 $10,761,080 $10,907,920 $12,038,025
Total People Sold 5 7 7 8
Total Sell Transactions 13 29 31 35
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 303
  Page 1 of 13  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Colangelo Dominick President and CEO   •       •      –    2024-04-18 4 AS $44.59 $780,325 D/D (17,500) 195,307 5%     
   Colangelo Dominick President and CEO   •       •      –    2024-04-18 4 OE $3.02 $52,850 D/D 17,500 212,807     -
   Colangelo Dominick President and CEO   •       •      –    2024-04-17 4 AS $46.47 $813,225 D/D (17,500) 195,307 5%     
   Colangelo Dominick President and CEO   •       •      –    2024-04-17 4 OE $3.02 $52,850 D/D 17,500 212,807     -
   Rubino Alan L   •       •      –    2024-04-09 4 OE $4.12 $12,360 D/D 3,000 20,594     -
   Zerbe Robert L Md   •       •      –    2024-03-27 4 AS $51.57 $169,046 D/D (3,278) 23,395 -12%     
   Zerbe Robert L Md   •       •      –    2024-03-27 4 OE $3.74 $12,260 D/D 3,278 26,673     -
   Colangelo Dominick President and CEO   •       •      –    2024-03-14 4 AS $44.02 $770,350 D/D (17,500) 194,870 4%     
   Colangelo Dominick President and CEO   •       •      –    2024-03-14 4 OE $3.02 $52,850 D/D 17,500 212,370     -
   Colangelo Dominick President and CEO   •       •      –    2024-03-13 4 AS $44.67 $781,725 D/D (17,500) 194,870 3%     
   Colangelo Dominick President and CEO   •       •      –    2024-03-13 4 OE $3.02 $52,850 D/D 17,500 212,370     -
   Halpin Michael Chief Operating Officer   •       •      –    2024-03-11 4 AS $44.71 $352,047 D/D (7,874) 949 3%     
   Flynn Sean C. SVP, General Counsel   •       •      –    2024-03-08 4/A AS $45.33 $367,853 D/D (8,115) 167     -
   Flynn Sean C. SVP, General Counsel   •       •      –    2024-03-08 4 S $45.33 $367,853 D/D (8,115) 167 -1%     
   Siegal Jonathan Principal Accounting Officer   •       •      –    2024-03-07 4 S $45.00 $73,530 D/D (1,634) 1,400 -1%     
   Zerbe Robert L Md   •       •      –    2024-02-20 4 AS $50.01 $36,107 D/D (722) 23,395 -7%     
   Zerbe Robert L Md   •       •      –    2024-02-20 4 OE $3.74 $2,700 D/D 722 24,117     -
   Flynn Sean C. SVP, General Counsel   •       •      –    2024-02-20 4 D $49.50 $160,875 D/D (3,250) 8,282     -
   Flynn Sean C. SVP, General Counsel   •       •      –    2024-02-20 4 OE $0.00 $0 D/D 7,075 9,059     -
   Halpin Michael Chief Operating Officer   •       •      –    2024-02-20 4 D $49.50 $283,685 D/D (5,731) 8,823     -
   Halpin Michael Chief Operating Officer   •       •      –    2024-02-20 4 OE $0.00 $0 D/D 11,887 10,155     -
   Mara Joseph Anthony Jr Chief Financial Officer   •       •      –    2024-02-20 4 D $49.50 $112,266 D/D (2,268) 19,288     -
   Mara Joseph Anthony Jr Chief Financial Officer   •       •      –    2024-02-20 4 OE $0.00 $0 D/D 7,380 20,097     -
   Hopper Jonathan Mark Chief Medical Officer   •       •      –    2024-02-20 4 D $49.50 $153,747 D/D (3,106) 57,953     -
   Hopper Jonathan Mark Chief Medical Officer   •       •      –    2024-02-20 4 OE $0.00 $0 D/D 7,075 58,695     -
  303 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 13
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us